Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

Trial Profile

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Sirolimus (Primary) ; Aspirin; Clopidogrel
  • Indications Angina pectoris; Ischaemic heart disorders; Myocardial infarction
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms HOST-IDEA
  • Most Recent Events

    • 19 Sep 2016 Planned number of patients changed from 2132 to 2152.
    • 01 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
    • 25 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top